Literature DB >> 18025055

Arsenic neurotoxicity--a review.

A Vahidnia1, G B van der Voet, F A de Wolff.   

Abstract

Arsenic (As) is one of the oldest poisons known to men. Its applications throughout history are wide and varied: murder, make-up, paint and even as a pesticide. Chronic As toxicity is a global environmental health problem, affecting millions of people in the USA and Germany to Bangladesh and Taiwan. Worldwide, As is released into the environment by smelting of various metals, combustion of fossil fuels, as herbicides and fungicides in agricultural products. The drinking water in many countries, which is tapped from natural geological resources, is also contaminated as a result of the high level of As in groundwater. The environmental fate of As is contamination of surface and groundwater with a contaminant level higher than 10 particle per billion (ppb) as set by World Health Organization (WHO). Arsenic exists in both organic and inorganic species and either form can also exist in a trivalent or pentavalent oxidation state. Long-term health effects of exposure to these As metabolites are severe and highly variable: skin and lung cancer, neurological effects, hypertension and cardiovascular diseases. Neurological effects of As may develop within a few hours after ingestion, but usually are seen in 2-8 weeks after exposure. It is usually a symmetrical sensorimotor neuropathy, often resembling the Guillain-Barré syndrome. The predominant clinical features of neuropathy are paresthesias, numbness and pain, particularly in the soles of the feet. Electrophysiological studies performed on patients with As neuropathy have revealed a reduced nerve conduction velocity, typical of those seen in axonal degeneration. Most of the adverse effects of As, are caused by inactivated enzymes in the cellular energy pathway, whereby As reacts with the thiol groups of proteins and enzymes and inhibits their catalytic activity. Furthermore, As-induced neurotoxicity, like many other neurodegenerative diseases, causes changes in cytoskeletal protein composition and hyperphosphorylation. These changes may lead to disorganization of the cytoskeletal framework, which is a potential mechanism of As-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025055     DOI: 10.1177/0960327107084539

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  63 in total

1.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

Review 2.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

3.  Inorganic Arsenic Induces NRF2-Regulated Antioxidant Defenses in Both Cerebral Cortex and Hippocampus in Vivo.

Authors:  Yang Zhang; Xiaoxu Duan; Jinlong Li; Shuo Zhao; Wei Li; Lu Zhao; Wei Li; Huifang Nie; Guifang Sun; Bing Li
Journal:  Neurochem Res       Date:  2016-05-10       Impact factor: 3.996

Review 4.  The relative impact of toxic heavy metals (THMs) (arsenic (As), cadmium (Cd), chromium (Cr)(VI), mercury (Hg), and lead (Pb)) on the total environment: an overview.

Authors:  Zeeshanur Rahman; Ved Pal Singh
Journal:  Environ Monit Assess       Date:  2019-06-08       Impact factor: 2.513

5.  From schizophrenia risk locus to schizophrenia genes.

Authors:  Patrick Sleiman; Hakon Hakonarson
Journal:  Nat Med       Date:  2016-06-07       Impact factor: 53.440

6.  Occupational neurotoxic diseases in taiwan.

Authors:  Chi-Hung Liu; Chu-Yun Huang; Chin-Chang Huang
Journal:  Saf Health Work       Date:  2012-11-30

7.  Perturbation of defense pathways by low-dose arsenic exposure in zebrafish embryos.

Authors:  Carolyn J Mattingly; Thomas H Hampton; Kimberly M Brothers; Nina E Griffin; Antonio Planchart
Journal:  Environ Health Perspect       Date:  2009-02-22       Impact factor: 9.031

8.  Association between arsenic exposure and plasma cholinesterase activity: a population based study in Bangladesh.

Authors:  Nurshad Ali; Md Ashraful Hoque; Abedul Haque; Kazi Abdus Salam; Md Rezaul Karim; Aminur Rahman; Khairul Islam; Zahangir Alam Saud; Md Abdul Khalek; Anwarul Azim Akhand; Mostaque Hossain; Abul Mandal; Md Rezaul Karim; Hideki Miyataka; Seiichiro Himeno; Khaled Hossain
Journal:  Environ Health       Date:  2010-07-10       Impact factor: 5.984

9.  Arsenic toxicity in the human nerve cell line SK-N-SH in the presence of chromium and copper.

Authors:  Ligang Hu; Justin B Greer; Helena Solo-Gabriele; Lynne A Fieber; Yong Cai
Journal:  Chemosphere       Date:  2013-03-06       Impact factor: 7.086

Review 10.  A systematic review of arsenic exposure and its social and mental health effects with special reference to Bangladesh.

Authors:  Johanna Brinkel; Mobarak H Khan; Alexander Kraemer
Journal:  Int J Environ Res Public Health       Date:  2009-05-08       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.